Clinical Trials
Sponsor:
Sponsor Study ID:
Study Title:
Melanoma Margins Trial (MelMarT II): A Phase III, Multi Centre, Multi National Randomized Control Trial investigating 1cm v 2cm Wide Excision Margins for Primary Cutaneous Melanoma
NCT Number:
NCT03860883
Phase:
III
Protocol Type:
Treatment
Age Group:
Adults
Disease Sites:
Melanoma, Skin
Study Objectives:
Patients with a primary invasive melanoma are recommended to undergo excision of the primary lesion with a wide margin. There is evidence that less radical margins of excision may be just as safe. This is a randomised controlled trial of 1 cm versus 2 cm margin of excision of the primary lesion for adult patients with stage II primary invasive cutaneous melanomas (AJCC 8th edition) to determine differences in disease-free survival. A reduction in margins is expected to improve patient quality of life.
Study Documents
(MUSC NetID required for document access)